Jon Frampton

21 - 30 out of 97Page size: 10

Publications

  1. Published

    Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research

    Sudha Sundar, Jean-Baptiste Cazier & Jon Frampton, 15 Feb 2018, In : The Lancet Oncology. 19, 2, p. e102–e112

    Research output: Contribution to journal › Article

  2. Published

    Inducible disruption of the c-myb gene allows allogeneic bone marrow transplantation without irradiation

    Jon Frampton, 1 Jun 2018, In : Journal of Immunological Methods. 457, p. 66-72

    Research output: Contribution to journal › Article

  3. Published

    Origin-specific Adhesive Interactions of Mesenchymal Stem Cells with Platelets Influence their Behaviour After Infusion.

    Julie Rayes, Stephen Watson, Philip Newsome, Neena Kalia, Jon Frampton, Helen McGettrick & Gerard Nash, Feb 2018, In : Stem cells (Dayton, Ohio).

    Research output: Contribution to journal › Article

  4. Published

    A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein

    Yotis Senis, Michael Tomlinson, Stephanie Dumon, Victoria Heath, Jennifer Spalton, Roy Bicknell, Jon Frampton, Ashley Martin, Mike Wakelam & Steve Watson, 27 Dec 2006, In : Molecular and Cellular Proteomics. 6, p. 548-564 17 p.

    Research output: Contribution to journal › Article

  5. Published

    EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall

    Jon Frampton, 1 May 2011, In : Journal of Thrombosis and Haemostasis. 9, 5, p. 1007-1019 13 p.

    Research output: Contribution to journal › Article

  6. Published

    A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells

    Jon Frampton, 1 Apr 2012, In : Science. 336, 6077, p. 86-90 5 p.

    Research output: Contribution to journal › Article

  7. Published

    CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex

    Giacomo Volpe, Jon Frampton, 24 Jan 2019, In : Leukemia. 33, p. 1608-1619 12 p.

    Research output: Contribution to journal › Article

  8. Published

    RCAS/SCL-TVA Animal Model Allows Targeted Delivery of Polyoma Middle T Oncogene to Vascular Endothelial Progenitors In vivo and Results in Hemangioma Development

    Jon Frampton, 15 Jun 2008, In : Clinical Cancer Research. 14, 12, p. 3948-3955 8 p.

    Research output: Contribution to journal › Article

  9. Published

    Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development

    Jon Frampton, 1 Aug 2006, In : Blood. 108, 3, p. 896-903 8 p.

    Research output: Contribution to journal › Article

  10. Published

    Determining c-Myb protein levels can isolate functional hematopoietic stem cell subtypes

    Paloma Garcia, Jon Frampton, Feb 2015, In : Stem Cells. 33, 2, p. 479-490 12 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...10 Next